Jaguar Health Files 8-K with Financials and Exhibits

Ticker: JAGX · Form: 8-K · Filed: Apr 30, 2025 · CIK: 1585608

Sentiment: neutral

Topics: financial-statements, exhibits, sec-filing

Related Tickers: JAGX

TL;DR

Jaguar Health dropped an 8-K, mostly financials & exhibits. Nothing earth-shattering in this snippet.

AI Summary

On April 30, 2025, Jaguar Health, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. No specific new material events or financial figures were detailed in the provided excerpt.

Why It Matters

This filing indicates that Jaguar Health is providing updated financial information and exhibits to the SEC, which is standard for public companies and may contain details relevant to investors.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report for financial statements and exhibits, not indicating any immediate new risks or significant events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Jaguar Health, Inc.?

The primary purpose of this 8-K filing is to report on financial statements and exhibits, along with other events and a Regulation FD disclosure, as of April 30, 2025.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on April 30, 2025.

What is Jaguar Health, Inc.'s state of incorporation?

Jaguar Health, Inc. is incorporated in Delaware.

What is the principal executive office address for Jaguar Health, Inc.?

The principal executive office address is 200 Pine Street Suite 400, San Francisco, California, 94104.

What is the telephone number listed for Jaguar Health, Inc.?

The telephone number listed for Jaguar Health, Inc. is (415) 371-8300.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2025 regarding Jaguar Health, Inc. (JAGX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing